TMO FY 2009 Earnings Report — Thermo Fisher Scientific Inc. Revenue & Financial Results | Market Cap Arena

Thermo Fisher Scientific Inc.TMO

FY 2009 Earnings

Reported February 26, 2010

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2009	Prior Q	FY 2008	QoQ Change	YoY Change
Revenue	$10.1B	—	$10.5B	—	-3.7%
Op. Income	$1.1B	—	$1.3B	—	-11.7%
Gross Margin	40.3%	—	40.4%	—	-0.2pp
Net Margin	8.4%	—	9.5%	—	-1.1pp
EPS (Diluted)	$2.01	—	$2.25	—	-10.7%
Free Cash Flow	$1.5B	—	$1.2B	—	25.6%

Revenue Flow

Item	Amount
REVENUE	$10.1B
Cost of Revenue	$6.0B
GROSS PROFIT	$4.1B
R&D Expenses	$246M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$2.7B
Other Expenses	$39M
Operating Expenses	$3.0B
Cost & Expenses	$9.0B
OPERATING INCOME	$1.1B
Interest Income	$16M
Interest Expense	$118M
Other Income/Expenses	-$191M
INCOME BEFORE TAX	$927M
Income Tax Expense	$76M
Net Income from Continuing Ops	$851M
Net Income from Discontinued Ops	$0
Other Adjustments	-$1M
NET INCOME	$850M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$850M
D&A	$787M
EBIT	$1.0B
EBITDA	$1.8B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$10.1B
Cost of Revenue	$6.0B
GROSS PROFIT	$4.1B
R&D Expenses	$246M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$2.7B
Other Expenses	$39M
Operating Expenses	$3.0B
Cost & Expenses	$9.0B
OPERATING INCOME	$1.1B
Interest Income	$16M
Interest Expense	$118M
Other Income/Expenses	-$191M
INCOME BEFORE TAX	$927M
Income Tax Expense	$76M
Net Income from Continuing Ops	$851M
Net Income from Discontinued Ops	$0
Other Adjustments	-$1M
NET INCOME	$850M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$850M
D&A	$787M
EBIT	$1.0B
EBITDA	$1.8B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$851M
Depreciation & Amortization	$787M
Stock-Based Compensation	$68M
Deferred Income Tax	-$244M
Other Non-Cash Items	$86M
Change in Working Capital	$110M
OPERATING CASH FLOW	$1.7B
Capital Expenditure	-$208M
Acquisitions (Net)	-$637M
Purchases of Investments	$13M
Sales/Maturities of Investments	$800.0K
Other Investing Activities	$2M
NET CASH FROM INVESTING	-$830M
Net Debt Issuance	-$200M
Common Stock Repurchased	-$415M
Common Dividends Paid	$0
Other Financing Activities	$3M
NET CASH FROM FINANCING	-$558M
FREE CASH FLOW	$1.5B
Net Change in Cash	$284M

Balance Sheet

Item	Amount
Cash & Equivalents	$1.6B
Short-Term Investments	$7M
Net Receivables	$1.4B
Inventory	$1.1B
Other Current Assets	$419M
TOTAL CURRENT ASSETS	$4.5B
PP&E (Net)	$1.3B
Goodwill	$9.0B
Intangible Assets	$6.3B
Long-Term Investments	$10M
Tax Assets	$0
Other Non-Current Assets	$430M
TOTAL NON-CURRENT ASSETS	$17.1B
TOTAL ASSETS	$21.6B
Account Payables	$534M
Short-Term Debt	$118M
Deferred Revenue	$140M
Other Current Liabilities	$534M
TOTAL CURRENT LIABILITIES	$1.6B
Long-Term Debt	$2.1B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$1.9B
Other Non-Current Liabilities	$555M
TOTAL NON-CURRENT LIABILITIES	$4.6B
TOTAL LIABILITIES	$6.2B
Common Stock	$424M
Additional Paid-In Capital	$11.1B
Retained Earnings	$4.4B
Treasury Stock	-$577M
Accum. Other Comp. Income	$92M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$15.4B
Minority Interest	$0
TOTAL EQUITY	$15.4B
TOTAL LIABILITIES & EQUITY	$21.6B
Total Debt	$2.2B
Net Debt	$619M